All News

Your diagnosis of an early-stage blood cancer, such as a MPN or MDS, means that something has changed in the way your bone marrow produces blood cells.

Here is an overview of cancers including bladder cancer, kidney cancer and testicular cancer.

This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer journey.

Colorectal cancer is a complex disease. Understanding its fundamental aspects can empower you to have more informed and productive conversations with your oncologist.

The FDA granted Breakthrough Therapy designation to olomorasib plus Keytruda for unresectable advanced or metastatic NSCLC with a KRAS G12C mutation.

Rising colorectal cancer rates in younger adults are prompting earlier screenings, with colonoscopy offering both detection and prevention.

Leaving a legacy is essential for many, especially for those who have faced cancer. We long for our friends and family to understand how cancer impacts our lives.

How can colonoscopy detect colorectal cancer early and prevent it by removing polyps, compared with other noninvasive screening methods?

TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder cancer.

As we head into Fall, I’ve been thinking about how much this season represents my daughter’s cancer experience for me.

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous data and biomarker insights.

CURE spoke with the author of “Between Two Kingdoms” and “The Book of Alchemy” about the latest chapter in her cancer journey.

The FDA granted two fast track designations to TT125-802, an investigational therapy, for the treatment of advanced/metastatic non-small cell lung cancer.

Advances in leukemia treatment now include targeted drugs, lighter chemotherapy and combination regimens that improve tolerance and reduce resistance.

Dr. David A. Taub discussed why Prostate Cancer Awareness Month marks a time to highlight early detection and evolving treatment in an interview with CURE.

Through exercise, meditation, and gratitude, I reset my mind and body, finding peace and strength in life after my cancer diagnosis.

In observation of Leukemia Awareness Month in September, CURE spoke with an expert about basics of the disease.

The FDA granted breakthrough device designation to the Haystack MRD test, which uses ctDNA to detect residual or recurrent stage 2 colorectal cancer.

Patients can best advocate for themselves by asking questions and remembering they have the right to be active participants in their care.

Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.

CURE spoke with Dr. Ryan Kahn of Miami Cancer Institute for Ovarian Cancer Awareness Month.

In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung cancer and brain cancer.

For me, standing up to cancer means honoring my wife’s melanoma journey by raising awareness, supporting early detection and research.

The FDA has approved the NDA for Camcevi ETM for the treatment of advanced prostate cancer.

The FDA approved Bildyos and Bilprevda as biosimilars to Prolia and Xgeva, expanding bone care options for osteoporosis, cancer and more.

Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian cancer in decades.

In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer.

Clara Mae Cirk, a 30-year-old diagnosed with stage 4 lung cancer, shares how cancer has reshaped her perspective on strength and self-care.